Carcinoembryonic antigen (CEA), a highly glycosylated protein with molecular weight of approximately 200 kDa, is one of the most widely used tumor markers for diagnosis, prognosis estimation and monitoring of malignant tumors such as pancreatic, colorectal, liver, breast and gastric cancers1,2. This evidence concerns the gene CEACAM5 and neoplasm.